Dominiek Catteeuw

Journal Article
A1
open access

A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state

Sandra Van Lint (UGent) , Alexander Van Parys (UGent) , Bram Van Den Eeckhout (UGent) , Niels Vandamme (UGent) , Stephane Plaisance, Annick Verhee (UGent) , Dominiek Catteeuw (UGent) , Elke Rogge (UGent) , Jennifer De Geest (UGent) , Nele Vanderroost (UGent) , et al.

(2023) MOLECULAR CANCER. 22(1).

Add to list

Journal Article
A1
open access

Mechanism of receptor assembly via the pleiotropic adipokine Leptin

Alexandra Tsirigotaki (UGent) , Ann Dansercoer (UGent) , Koen Verschueren (UGent) , Iva Marković (UGent) , Christoph Pollmann, Maximillian Hafer, Jan Félix (UGent) , Catherine Birck, Wouter Van Putte, Dominiek Catteeuw (UGent) , et al.

(2023) NATURE STRUCTURAL & MOLECULAR BIOLOGY. 30(4). p.551-563

Add to list

Journal Article
A1
open access

Recent advancements in tracking bacterial effector protein translocation

Julie Braet (UGent) , Dominiek Catteeuw (UGent) and Petra Van Damme (UGent)

(2022) MICROORGANISMS. 10(2).

Add to list

Targeting interferon activity to dendritic cells enables in vivo tolerization and protection against EAE in mice

Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Dominiek Catteeuw (UGent) , Shengru Pang, Franciane Paul, Elke Rogge (UGent) , Annick Verhee (UGent) , Marco Prinz, Niko Kley, Gilles Uzé, et al.

(2019) JOURNAL OF AUTOIMMUNITY. 97. p.70-76

Add to list

Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments

Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Franciane Paul, Genevieve Garcin, Stefaan De Koker (UGent) , Alexander Van Parys (UGent) , Thomas Wüest (UGent) , Sarah Gerlo (UGent) , José Van Der Heyden (UGent) , Yan Bordat, et al.

(2018) CANCER RESEARCH. 78(2). p.463-474

Add to list

A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment

Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Geneviève Garcin, Jennyfer Bultinck (UGent) , Franciane Paul, Sarah Gerlo (UGent) , José Van Der Heyden (UGent) , Yann Bordat, Dominiek Catteeuw (UGent) , Lode De Cauwer (UGent) , et al.

(2017) ONCOIMMUNOLOGY. 7(3).

Add to list

Journal Article
A1
open access

Leptin's metabolic and immune functions can be uncoupled at the ligand/receptor interaction level

Lennart Zabeau (UGent) , Cathy J Jensen, Sylvie Seeuws (UGent) , Koen Venken (UGent) , Annick Verhee (UGent) , Dominiek Catteeuw (UGent) , Geert van Loo (UGent) , Hui Chen, Ken Walder, Jacob Hollis, et al.

(2015) CELLULAR AND MOLECULAR LIFE SCIENCES. 72(3). p.629-644

Add to list

A bidirectional crosstalk between iNKT cells and adipocytes mediated by leptin modulates susceptibility for T cell mediated hepatitis

Koen Venken (UGent) , Sylvie Seeuws (UGent) , Lennart Zabeau (UGent) , Peggy Jacques (UGent) , Tine Decruy (UGent) , Julie Coudenys (UGent) , Eveline Verheugen (UGent) , Fien Windels (UGent) , Dominiek Catteeuw (UGent) , Michael Drennan (UGent) , et al.

(2014) JOURNAL OF HEPATOLOGY. 60(1). p.175-182

Add to list

Journal Article
A1
open access

Random mutagenesis MAPPIT analysis identifies binding sites for Vif and Gag in both cytidine deaminase domains of Apobec3G

Isabel Uyttendaele (UGent) , Delphine Lavens (UGent) , Dominiek Catteeuw (UGent) , Irma Lemmens (UGent) , Celia Bovijn (UGent) , Jan Tavernier (UGent) and Frank Peelman (UGent)

(2012) PLoS ONE. 7(9).

Add to list

Identification of interaction sites for dimerization and adapter recruitment in Toll/interleukin-1 receptor (TIR) domain of Toll-like receptor 4

Celia Bovijn (UGent) , Peter Ulrichts (UGent) , Anne-Sophie De Smet (UGent) , Dominiek Catteeuw (UGent) , Rudi Beyaert (UGent) , Jan Tavernier (UGent) and Frank Peelman (UGent)

(2012) JOURNAL OF BIOLOGICAL CHEMISTRY. 287(6). p.4088-4098

Academic Bibliography

Dominiek Catteeuw

A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state

Mechanism of receptor assembly via the pleiotropic adipokine Leptin

Recent advancements in tracking bacterial effector protein translocation

Targeting interferon activity to dendritic cells enables in vivo tolerization and protection against EAE in mice

Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments

A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment

Leptin's metabolic and immune functions can be uncoupled at the ligand/receptor interaction level

A bidirectional crosstalk between iNKT cells and adipocytes mediated by leptin modulates susceptibility for T cell mediated hepatitis

Random mutagenesis MAPPIT analysis identifies binding sites for Vif and Gag in both cytidine deaminase domains of Apobec3G

Identification of interaction sites for dimerization and adapter recruitment in Toll/interleukin-1 receptor (TIR) domain of Toll-like receptor 4

Contents

Support

Contact